Recognized globally as experts in neurocognition and pharmacologic treatment of CNS disorders, the NeuroCog Trials Scientific Team has been instrumental in hundreds of research projects and clinical trials. Below are links to our articles and other published works that comprise a portion of our scientific library.

Cognitive burden of anticholinergic medications in psychotic disorders

Posted

Patients with psychotic disorders are often treated with numerous medications, many of which have anticholinergic activity. We assessed cognition in relation to the cumulative anticholinergic burden of multiple drugs included in treatment regimens of participants from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Clinically … Continued

Tagged: , , , , ,

Development and Validation of the Tablet-based Brief Assessment of Cognition (BAC App) for Schizophrenia

Posted

This poster was presented at the International Congress on Schizophrenia Research in San Diego 24-28 March 2017. The Brief Assessment of Cognition in Schizophrenia (BACS) is a pen-and-paper cognitive assessment tool that has been used in hundreds of research studies and clinical trials, and has … Continued

Tagged: , , , , ,

Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia

Posted

The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment of cognition that involves interviews with patients and informants. The SCoRS has shown good reliability, validity, and sensitivity to cognitive impairment in schizophrenia, with the advantage of brief administration and scoring time. The present study … Continued

Tagged: , , , ,
Page 1 Page 2 Page 3 Page 50